Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

4.7K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

333
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
333

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term Clinical Outcomes of Radiofrequency Ablation for Pathologically Diagnosed T1a Renal Cell Carcinoma: A 10-Year Single-center Experience.

Interventional radiology (Higashimatsuyama-shi (Japan)·2026
Same author

Tuning the tumor, trafficking the T cell: sIRE opens the door for solid tumor CAR T cells.

Molecular therapy. Oncology·2026
Same author

Automated Cryoprobe Planning Using a Large Language Model: A Geometric Approach to Optimize Probe Placement Based on Isotherm Data.

Cardiovascular and interventional radiology·2026
Same author

T-Cell Clonal Expansion in Peripheral Blood Following Interventional Radiology Procedures for Metastatic Liver Cancer.

Cancers·2026
Same author

Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.

Journal for immunotherapy of cancer·2026
Same author

Irreversible Electroporation Enhances Solid Tumor Infiltration and Selective Cancer Cell Lysis by CAR T Cells.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Related Experiment Video

Updated: Mar 22, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.3K

Peripheral Blood Regulatory T-Cell and Type 1 Helper T-Cell Population Decrease after Hepatic Artery Embolization.

Haruyuki Takaki1, Naoko Imai2, Thomas T Contessa3

  • 1Department of Radiology, Hyogo Collage of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.

Journal of Vascular and Interventional Radiology : JVIR
|April 17, 2016
PubMed
Summary

Hepatic artery embolization (HAE) significantly decreases CD4(+) T cells, including regulatory T cells (Treg) and type 1 helper T cells (Th1). These changes in T-cell populations may impact treatment outcomes for liver tumors.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.5K
Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
10:04

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

5.9K

Related Experiment Videos

Last Updated: Mar 22, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.3K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.5K
Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
10:04

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

5.9K

Area of Science:

  • Immunology
  • Interventional Radiology
  • Oncology

Background:

  • Hepatic artery embolization (HAE) is a common treatment for liver tumors.
  • The impact of HAE on systemic immunity, particularly T-cell populations, requires further investigation.

Purpose of the Study:

  • To evaluate changes in peripheral blood T-cell populations following bland hepatic artery embolization (HAE).

Main Methods:

  • Bland HAE was performed on 12 patients with liver tumors.
  • Peripheral blood T-cell subsets, including CD4(+) T cells, Th1, Th2, and regulatory T cells (Treg), were analyzed using flow cytometry before and after HAE.
  • Statistical analysis compared T-cell populations pre- and post-procedure.

Main Results:

  • A significant decrease in overall CD4(+) T cells was observed in both early and follow-up periods after HAE.
  • Regulatory T cells (Treg) and type 1 helper T cells (Th1) showed significant reductions in the early post-HAE period.
  • Extrahepatic disease presence correlated with a decrease in regulatory T cells (Treg).

Conclusions:

  • Bland HAE alters the peripheral blood T-cell profile, characterized by reductions in Treg and Th1 populations.
  • These immunomodulatory effects of HAE warrant further study in the context of liver tumor treatment.